Becton, Dickinson and Company BDX International — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's international — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's international — revenue?
- Becton, Dickinson and Company (BDX) reported international — revenue of $1.8B in Q1 2026.
- How has Becton, Dickinson and Company's international — revenue changed year-over-year?
- Becton, Dickinson and Company's international — revenue increased by 5.5% year-over-year, from $1.7B to $1.8B.
- What is the long-term trend for Becton, Dickinson and Company's international — revenue?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's international — revenue has grown at a -1.2% compound annual growth rate (CAGR), from $9.01B to $8.59B.
- What does international — revenue mean?
- This metric represents the total net sales generated by the company from operations and customers located outside of its primary domestic market. It captures the geographic diversification of the business and the company's ability to penetrate global healthcare markets. Monitoring this figure helps investors assess exposure to foreign currency fluctuations, international regulatory environments, and global demand trends for medical devices.